0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
China Attention Deficit Hyperactivity Disorder (ADHD) Market Report & Forecast 2021-2027
Published Date: October 2021
|
Report Code: QYRE-Auto-21N5737
Home | Market Reports | Health | Health Conditions | Neurological Conditions
China Attention Deficit Hyperactivity Disorder ADHD Market Report Forecast 2021 2027

China Attention Deficit Hyperactivity Disorder (ADHD) Market Report & Forecast 2021-2027

Code: QYRE-Auto-21N5737
Report
October 2021
92 Pages
QYResearch
Region: Global, China,
Description
Table of Content
Tables & Figures
China Attention Deficit Hyperactivity Disorder (ADHD) Market, By Type, 2016-2021, 2022-2027 ($ Millions)
China Attention Deficit Hyperactivity Disorder (ADHD) Market Segment Percentages, By Type, 2020 (%)
Stimulant
Non-stimulant
China Attention Deficit Hyperactivity Disorder (ADHD) Market, By Distribution Channel, 2016-2021, 2022-2027 ($ Millions)
China Attention Deficit Hyperactivity Disorder (ADHD) Market Segment Percentages, By Distribution Channel, 2020 (%)
Hospital Pharmacy
Retail Pharmacy
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Attention Deficit Hyperactivity Disorder (ADHD) revenues in China market, 2016-2021 (Estimated), ($ millions)
Key companies Attention Deficit Hyperactivity Disorder (ADHD) revenues share in China market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

Takeda
Johnson & Johnson
Novartis
Eli Lilly
Tris Pharma
Neos Therapeutics
Mallinckrodt
Amneal Pharmaceuticals
Noven Pharmaceuticals
Purdue Parma
CTFH
1 Introduction to Research & Analysis Reports
1.1 Attention Deficit Hyperactivity Disorder (ADHD) Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Distribution Channel
1.3 China Attention Deficit Hyperactivity Disorder (ADHD) Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Attention Deficit Hyperactivity Disorder (ADHD) Overall Market Size
2.1 China Attention Deficit Hyperactivity Disorder (ADHD) Market Size: 2021 VS 2027
2.2 China Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Attention Deficit Hyperactivity Disorder (ADHD) Players in China Market
3.2 Top China Attention Deficit Hyperactivity Disorder (ADHD) Companies Ranked by Revenue
3.3 China Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Companies
3.4 Top 3 and Top 5 Attention Deficit Hyperactivity Disorder (ADHD) Companies in China Market, by Revenue in 2020
3.5 Companies Attention Deficit Hyperactivity Disorder (ADHD) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Attention Deficit Hyperactivity Disorder (ADHD) Players in China Market
3.6.1 List of Tier 1 Attention Deficit Hyperactivity Disorder (ADHD) Companies in China
3.6.2 List of Tier 2 and Tier 3 Attention Deficit Hyperactivity Disorder (ADHD) Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Attention Deficit Hyperactivity Disorder (ADHD) Market Size Markets, 2021 & 2027
4.1.2 Stimulant
4.1.3 Non-stimulant
4.2 By Type - China Attention Deficit Hyperactivity Disorder (ADHD) Revenue & Forecasts
4.2.1 By Type - China Attention Deficit Hyperactivity Disorder (ADHD) Revenue, 2016-2021
4.2.2 By Type - China Attention Deficit Hyperactivity Disorder (ADHD) Revenue, 2022-2027
4.2.3 By Type - China Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share, 2016-2027
5 Sights by Distribution Channel
5.1 Overview
5.1.1 By Distribution Channel - China Attention Deficit Hyperactivity Disorder (ADHD) Market Size, 2021 & 2027
5.1.2 Hospital Pharmacy
5.1.3 Retail Pharmacy
5.2 By Distribution Channel - China Attention Deficit Hyperactivity Disorder (ADHD) Revenue & Forecasts
5.2.1 By Distribution Channel - China Attention Deficit Hyperactivity Disorder (ADHD) Revenue, 2016-2021
5.2.2 By Distribution Channel - China Attention Deficit Hyperactivity Disorder (ADHD) Revenue, 2022-2027
5.2.3 By Distribution Channel - China Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share, 2016-2027
6 Attention Deficit Hyperactivity Disorder (ADHD) Companies Profiles
6.1 Takeda
6.1.1 Takeda Company Details
6.1.2 Takeda Business Overview
6.1.3 Takeda Attention Deficit Hyperactivity Disorder (ADHD) Introduction
6.1.4 Takeda Attention Deficit Hyperactivity Disorder (ADHD) Revenue in China Market (2016-2021)
6.1.5 Takeda Recent Developments
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Company Details
6.2.2 Johnson & Johnson Business Overview
6.2.3 Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Introduction
6.2.4 Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Revenue in China Market (2016-2021)
6.2.5 Johnson & Johnson Recent Developments
6.3 Novartis
6.3.1 Novartis Company Details
6.3.2 Novartis Business Overview
6.3.3 Novartis Attention Deficit Hyperactivity Disorder (ADHD) Introduction
6.3.4 Novartis Attention Deficit Hyperactivity Disorder (ADHD) Revenue in China Market (2016-2021)
6.3.5 Novartis Recent Developments
6.4 Eli Lilly
6.4.1 Eli Lilly Company Details
6.4.2 Eli Lilly Business Overview
6.4.3 Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Introduction
6.4.4 Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Revenue in China Market (2016-2021)
6.4.5 Eli Lilly Recent Developments
6.5 Tris Pharma
6.5.1 Tris Pharma Company Details
6.5.2 Tris Pharma Business Overview
6.5.3 Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Introduction
6.5.4 Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Revenue in China Market (2016-2021)
6.5.5 Tris Pharma Recent Developments
6.6 Neos Therapeutics
6.6.1 Neos Therapeutics Company Details
6.6.2 Neos Therapeutics Business Overview
6.6.3 Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Introduction
6.6.4 Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Revenue in China Market (2016-2021)
6.6.5 Neos Therapeutics Recent Developments
6.7 Mallinckrodt
6.7.1 Mallinckrodt Company Details
6.7.2 Mallinckrodt Business Overview
6.7.3 Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Introduction
6.7.4 Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Revenue in China Market (2016-2021)
6.7.5 Mallinckrodt Recent Developments
6.8 Amneal Pharmaceuticals
6.8.1 Amneal Pharmaceuticals Company Details
6.8.2 Amneal Pharmaceuticals Business Overview
6.8.3 Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Introduction
6.8.4 Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Revenue in China Market (2016-2021)
6.8.5 Amneal Pharmaceuticals Recent Developments
6.9 Noven Pharmaceuticals
6.9.1 Noven Pharmaceuticals Company Details
6.9.2 Noven Pharmaceuticals Business Overview
6.9.3 Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Introduction
6.9.4 Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Revenue in China Market (2016-2021)
6.9.5 Noven Pharmaceuticals Recent Developments
6.10 Purdue Parma
6.10.1 Purdue Parma Company Details
6.10.2 Purdue Parma Business Overview
6.10.3 Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Introduction
6.10.4 Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Revenue in China Market (2016-2021)
6.10.5 Purdue Parma Recent Developments
6.11 CTFH
6.11.1 CTFH Company Details
6.11.2 CTFH Business Overview
6.11.3 CTFH Attention Deficit Hyperactivity Disorder (ADHD) Introduction
6.11.4 CTFH Attention Deficit Hyperactivity Disorder (ADHD) Revenue in China Market (2016-2021)
6.11.5 CTFH Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Tables
    Table 1. Attention Deficit Hyperactivity Disorder (ADHD) Market Opportunities & Trends in China Market
    Table 2. Attention Deficit Hyperactivity Disorder (ADHD) Market Drivers in China Market
    Table 3. Attention Deficit Hyperactivity Disorder (ADHD) Market Restraints in China Market
    Table 4. Key Players of Attention Deficit Hyperactivity Disorder (ADHD) in China Market
    Table 5. Top Attention Deficit Hyperactivity Disorder (ADHD) Players in China Market, Ranking by Revenue (2019)
    Table 6. China Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Companies, (US$, Mn), 2016-2021
    Table 7. China Attention Deficit Hyperactivity Disorder (ADHD) Revenue Share by Companies, 2016-2021
    Table 8. Companies Attention Deficit Hyperactivity Disorder (ADHD) Product Type
    Table 9. List of Tier 1 Attention Deficit Hyperactivity Disorder (ADHD) Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 10. List of Tier 2 and Tier 3 Attention Deficit Hyperactivity Disorder (ADHD) Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 11. By Type – China Attention Deficit Hyperactivity Disorder (ADHD) Revenue, (US$, Mn), 2021 & 2027
    Table 12. By Type - China Attention Deficit Hyperactivity Disorder (ADHD) Revenue (US$, Mn), 2016-2021
    Table 13. By Type - China Attention Deficit Hyperactivity Disorder (ADHD) Revenue (US$, Mn), 2022-2027
    Table 14. By Distribution Channel – China Attention Deficit Hyperactivity Disorder (ADHD) Revenue, (US$, Mn), 2021 VS 2027
    Table 15. By Distribution Channel - China Attention Deficit Hyperactivity Disorder (ADHD) Revenue (US$, Mn), 2016-2021
    Table 16. By Distribution Channel - China Attention Deficit Hyperactivity Disorder (ADHD) Revenue (US$, Mn), 2022-2027
    Table 17. Takeda Company Details
    Table 18. Takeda Business Overview
    Table 19. Takeda Attention Deficit Hyperactivity Disorder (ADHD) Product
    Table 20. Takeda Attention Deficit Hyperactivity Disorder (ADHD) Revenue in China Market (2016-2021) & (US$ Million)
    Table 21. Takeda Recent Developments
    Table 22. Johnson & Johnson Company Details
    Table 23. Johnson & Johnson Business Overview
    Table 24. Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Product
    Table 25. Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Revenue in China Market (2016-2021) & (US$ Million)
    Table 26. Johnson & Johnson Recent Developments
    Table 27. Novartis Company Details
    Table 28. Novartis Business Overview
    Table 29. Novartis Attention Deficit Hyperactivity Disorder (ADHD) Product
    Table 30. Novartis Attention Deficit Hyperactivity Disorder (ADHD) Revenue in China Market (2016-2021) & (US$ Million)
    Table 31. Novartis Recent Developments
    Table 32. Eli Lilly Company Details
    Table 33. Eli Lilly Business Overview
    Table 34. Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Product
    Table 35. Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Revenue in China Market (2016-2021) & (US$ Million)
    Table 36. Eli Lilly Recent Developments
    Table 37. Tris Pharma Company Details
    Table 38. Tris Pharma Business Overview
    Table 39. Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Product
    Table 40. Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Revenue in China Market (2016-2021) & (US$ Million)
    Table 41. Tris Pharma Recent Developments
    Table 42. Neos Therapeutics Company Details
    Table 43. Neos Therapeutics Business Overview
    Table 44. Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Product
    Table 45. Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Revenue in China Market (2016-2021) & (US$ Million)
    Table 46. Neos Therapeutics Recent Developments
    Table 47. Mallinckrodt Company Details
    Table 48. Mallinckrodt Business Overview
    Table 49. Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Product
    Table 50. Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Revenue in China Market (2016-2021) & (US$ Million)
    Table 51. Mallinckrodt Recent Developments
    Table 52. Amneal Pharmaceuticals Company Details
    Table 53. Amneal Pharmaceuticals Business Overview
    Table 54. Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Product
    Table 55. Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Revenue in China Market (2016-2021) & (US$ Million)
    Table 56. Amneal Pharmaceuticals Recent Developments
    Table 57. Noven Pharmaceuticals Company Details
    Table 58. Noven Pharmaceuticals Business Overview
    Table 59. Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Product
    Table 60. Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Revenue in China Market (2016-2021) & (US$ Million)
    Table 61. Noven Pharmaceuticals Recent Developments
    Table 62. Purdue Parma Company Details
    Table 63. Purdue Parma Business Overview
    Table 64. Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Product
    Table 65. Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Revenue in China Market (2016-2021) & (US$ Million)
    Table 66. Purdue Parma Recent Developments
    Table 67. CTFH Company Details
    Table 68. CTFH Business Overview
    Table 69. CTFH Attention Deficit Hyperactivity Disorder (ADHD) Product
    Table 70. CTFH Attention Deficit Hyperactivity Disorder (ADHD) Revenue in China Market (2016-2021) & (US$ Million)
    Table 71. CTFH Recent Developments
List of Figures
    Figure 1. Attention Deficit Hyperactivity Disorder (ADHD) Segment by Type
    Figure 2. Attention Deficit Hyperactivity Disorder (ADHD) Segment by Distribution Channel
    Figure 3. China Attention Deficit Hyperactivity Disorder (ADHD) Market Overview: 2020
    Figure 4. China Attention Deficit Hyperactivity Disorder (ADHD) Market Size: 2021 VS 2027 (US$, Mn)
    Figure 5. China Attention Deficit Hyperactivity Disorder (ADHD) Revenue, 2016-2027 (US$, Mn)
    Figure 6. The Top 3 and 5 Players Market Share by Attention Deficit Hyperactivity Disorder (ADHD) Revenue in 2020
    Figure 7. By Type - China Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share, 2016-2027
    Figure 8. By Distribution Channel - China Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share, 2016-2027
    Figure 9. Takeda Attention Deficit Hyperactivity Disorder (ADHD) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 10. Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 11. Novartis Attention Deficit Hyperactivity Disorder (ADHD) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 12. Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 13. Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 14. Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 15. Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 16. Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 17. Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 18. Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 19. CTFH Attention Deficit Hyperactivity Disorder (ADHD) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3400
This license allows only one user to access the PDF.

Electronic (PDF)
$5100
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$6800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Seventh Sense AI

RELATED REPORTS

Global and United States Levodopa Market Insights Forecast to 2027
Global and United States Levodopa Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-15B7475
Sat Nov 20 00:00:00 UTC 2021

Add to Cart

Global and China Neurosurgical Operating Room Table Market Insights Forecast to 2027
Global and China Neurosurgical Operating Room Table Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-10H7225
Tue Nov 02 00:00:00 UTC 2021

Add to Cart

Global and China Deep Brain Stimulation System Market Insights Forecast to 2027
Global and China Deep Brain Stimulation System Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-10Z6921
Mon Oct 25 00:00:00 UTC 2021

Add to Cart

China Autism Spectrum Disorder Diagnosis and Therapeutics Market Report Forecast 2021 2027
China Autism Spectrum Disorder Diagnosis and Therapeutics Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-6U7133
Sat Oct 02 00:00:00 UTC 2021

Add to Cart